Reuters logo
BRIEF-Theravance Biopharma reports encouraging data from first cohort of patients in Phase 1b clinical trial of TD-1473 in ulcerative colitis
2017年8月8日 / 晚上9点23分 / 3 个月前

BRIEF-Theravance Biopharma reports encouraging data from first cohort of patients in Phase 1b clinical trial of TD-1473 in ulcerative colitis

Aug 8 (Reuters) - Theravance Biopharma Inc

* Theravance Biopharma Inc says plans to progress TD-1473 into induction and maintenance study in 2018

* Theravance Biopharma Inc says in first cohort, there were no moderate or serious adverse events related to TD-1473 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below